Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Tigenix Nv (NASDAQ: TIG)

$16.85 USD -$0.15 (-0.88%)
Last Price $16.85
Net Change $-0.15 (-0.88%)
Bid $0
Ask Price $0
Open Price $17.02
Previous Close Price $17
High Price $17.08
Low Price $16.85
Number of Trades 22
Volume 4,696
Fifty Two Week High $17.65 (2017-05-10)
Fifty Two Week Low $10.77 (2016-12-15)
Average Daily Volume 10,905
Share Outstanding 13,000 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $0
Recent Earnings $
Annual EPS $0
Last Quarter EPS $
Market Capitalization $0.22B
Insider Shareholders % 0%
Annual Revenue $0B
No. Shares Outstanding 13,000
Inst. Shareholder % 8.16%
Annual Net Income $0B
TTM Net Profit Margin $100
1-Year Return 45.3%
3-Year Return 45.3%
5-Year Return 45.3%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD %
Dividends per Share $
Stock Split Ratio
Beta
TiGenix NV is a biopharmaceutical company. It focused on developing and commercializing novel therapeutics for allogeneic or donor-derived, expanded stem cells. The company's product platform consists of Cx601 and Cx611 which are in clinical trial stage. It operates primarily in Madrid, Spain. TiGenix NV is based in Leuven, Belgium.

TIG News & Stock Updates